European Archives - Page 1066 of 1157 - European Medical Journal

EMJ

The development of genomic tests and how validation affects their use in the clinic

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…

EMJ

2015 NCRI Cancer Conference: Francis Crick Institute scientists

Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, discusses topics covered…

EMJ

Clonal evolution in colorectal cancer

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Alberto Bardelli, PhD talks about clonal evolution in colorectal cancer. He also…

EMJ

Update on CheckMate 067, an advanced melanoma clinical trial

James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or Nivolumab plus Ipilimumab versus Ipilimumab…

EMJ

Physical activity levels and barriers to exercise referral among patients with cancer

Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients with cancer, at the…

EMJ

The debate between prevention and cure of breast cancer by Prof. Rob Coleman

Prof. Rob Coleman gives an overview of the session “This house believes we should stop focussing on the causes of breast cancer and get on with…

EMJ

2015 NCRI Cancer Conference: Featured sessions

Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…

EMJ

2015 NCRI Cancer Conference: The highlights

Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…

EMJ

Current status and future prospective of Trial Assigning IndividuaLized Options for Treatment (Rx)

At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…

EMJ

Study Shows Prostate Cancer Screening under Age of 55 May be of Limited Value

Barcelona, 14 November 2015: Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after…